Vorinostat

Small molecule

Approvedregulatory verdict

Evidence outlook

Approved: Cutaneous T-Cell Lymphoma

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

Also approved (2)
JP
  • Treatment of cutaneous T-cell lymphoma
Product first approved 2011PMDA
CA
  • ZOLINZA® (vorinostat) is indicated for: • the treatment of cutaneous manifestations in patients with advanced cutaneous T-cell lymphoma (CTCL) who have progressive, persistent or recurrent disease subsequent to prior systemic therapies. The indication was approved based on response rate demonstrated in a single-arm phase II study (see section 14 Clinical Trials)
Product first approved 2009Health Canada

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (5)
Cutaneous T-Cell Lymphoma
NCT01386398 · European Organisation for Research and Treatment of Cancer - EORTC
— · Lymphoma
What this study did
Other / comorbidity
NCT01554852 · University of Leeds
2010-05 – 2022-12 · Multiple Myeloma
What this study did
NCT00128102 · Merck Sharp & Dohme LLC
2005-06-30 – 2011-11-21 · Mesothelioma, Lung Cancer
What this study did
Phase 2/3 (3)
Other / comorbidity
NCT03117751 · St. Jude Children's Research Hospital
2017-03-29 – 2028-09-30 · Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma
What this study did
NCT01236560 · National Cancer Institute (NCI)
2011-01-26 – 2023-12-31 · Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma, Childhood Cerebral Anaplastic Astrocytoma, Childhood Spinal Cord Neoplasm
What this study did
NCT00473889 · Merck Sharp & Dohme LLC
2007-05 – 2008-12 · Stage IIIB or IV Non-Small Cell Lung Cancer
What this study did
Phase 2 (85)
Cutaneous T-Cell Lymphoma
NCT00958074 · University of Washington
2009-07 – 2013-11 · Cutaneous T-cell Lymphoma Stage I, Cutaneous T-cell Lymphoma Stage II, Cutaneous T-cell Lymphoma Stage III, Cutaneous T-cell Lymphoma Stage IV
What this study did
Other / comorbidity
NCT02559778 · Giselle Sholler
2015-09 – 2035-09 · Neuroblastoma
What this study did
NCT07261241 · New Approaches to Neuroblastoma Therapy Consortium
2026-12-31 – 2031-12-31 · Neuroblastoma
What this study did
NCT06995521 · Sung Won Choi
2026-12 – 2028-09 · GVHD
What this study did
NCT06145633 · Fred Hutchinson Cancer Center
2024-09-18 – 2027-12-30 · Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
What this study did
NCT01522976 · National Cancer Institute (NCI)
2012-03-01 – 2027-03-31 · Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome/Acute Myeloid Leukemia
What this study did
NCT00616967 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2008-05 – 2027-02 · Breast Cancer
What this study did
NCT01587352 · National Cancer Institute (NCI)
2012-05-29 – 2026-12-31 · Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7
What this study did
NCT05608369 · Case Comprehensive Cancer Center
2025-06-01 – 2026-02-01 · HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Hypopharynx
What this study did
NCT04339751 · National Institute of Neurological Disorders and Stroke (NINDS)
2025-04-11 – 2025-04-11 · Cushing's Disease
What this study did
NCT03561259 · Jubilant DraxImage Inc.
2019-10-21 – 2025-04 · Neuroblastoma, Neuroectodermal Tumors, Neoplasms
What this study did
NCT04357873 · UNICANCER
2020-10-28 – 2024-11-26 · Squamous Cell Lung Cancer, Vulvar Cancer, Penile Cancer, Cervix Cancer, Head and Neck Squamous Cell Carcinoma, Anal Cancer
What this study did
NCT03382834 · National Institute of Allergy and Infectious Diseases (NIAID)
2018-04-26 – 2023-07-27 · HIV Infections
What this study did
NCT04190056 · University of California, San Francisco
2021-03-11 – 2023-06-15 · Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
What this study did
NCT02336074 · Imperial College London
2015-11-27 – 2023-03-31 · HIV
What this study did
NCT04220008 · M.D. Anderson Cancer Center
2021-10-29 – 2021-10-29 · Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma, Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
What this study did
NCT02035137 · New Approaches to Neuroblastoma Therapy Consortium
2014-07 – 2021-02-26 · Neuroblastoma
What this study did
NCT01617226 · University of Birmingham
2012-09 – 2020-12 · Leukemia, Myeloid, Acute
What this study did
NCT03894826 · University of Calgary
2018-12-10 – 2020-10 · Refractory Epilepsy
What this study did
NCT00992446 · Fred Hutchinson Cancer Center
2010-09-02 – 2019-10-29 · Adult Diffuse Large B-Cell Lymphoma, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Non-Hodgkin Lymphoma
What this study did
NCT02395627 · University of California, San Francisco
2015-05-04 – 2019-06-08 · Breast Neoplasms
What this study did
NCT03509207 · Medical University of Graz
2017-12-14 – 2019-02-04 · Leiomyosarcoma, Endometrial Stromal Tumors, Carcinosarcomas Uterine
What this study did
NCT01593670 · Masonic Cancer Center, University of Minnesota
2013-03 – 2018-10-23 · Myelodysplastic Syndrome
What this study did
NCT01720875 · University of Leeds
2013-08-09 – 2018-08-29 · Multiple Myeloma
What this study did
NCT01175980 · National Cancer Institute (NCI)
2010-08-06 – 2018-08-01 · Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma, Stage III Major Salivary Gland Cancer AJCC v7, Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7, Stage IVA Major Salivary Gland Cancer AJCC v7, Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7, Stage IVB Major Salivary Gland Cancer AJCC v7, Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7, Stage IVC Major Salivary Gland Cancer AJCC v7, Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7, Tongue Carcinoma
What this study did
NCT02316340 · The University of Texas Health Science Center at San Antonio
2015-02-11 – 2018-04-16 · Colorectal Cancer
What this study did
NCT01365065 · Bayside Health
2011-05 – 2018-01 · HIV Positive
What this study did
NCT00703664 · National Cancer Institute (NCI)
2008-07-09 – 2017-12-01 · Recurrent Mantle Cell Lymphoma, Recurrent Non-Hodgkin Lymphoma
What this study did
NCT01790568 · University of Michigan Rogel Cancer Center
2014-12 – 2017-10-31 · Graft vs Host Disease, Hematologic Neoplasms, Non-Neoplastic Hematologic and Lymphocytic Disorder
What this study did
NCT00948064 · M.D. Anderson Cancer Center
2009-09-08 – 2017-08-03 · Leukemia
What this study did
NCT00720876 · City of Hope Medical Center
2008-07-23 – 2017-06-08 · Lymphoma
What this study did
NCT00839956 · Fred Hutchinson Cancer Center
2009-02 – 2017-03-31 · DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma
What this study did
NCT00764517 · OHSU Knight Cancer Institute
2008-08 – 2017-03 · Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Indolent Adult Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma
What this study did
NCT01492881 · UNC Lineberger Comprehensive Cancer Center
2012-04 – 2017-01 · Multiple Myeloma
What this study did
NCT02419755 · St. Jude Children's Research Hospital
2015-04-14 – 2016-12-31 · Mixed Lineage Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoid Leukemia
What this study did
NCT01267240 · National Cancer Institute (NCI)
2010-12 – 2016-10 · Paranasal Sinus Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Oral Cavity Squamous Cell Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma, Stage IVA Hypopharyngeal Squamous Cell Carcinoma, Stage IVA Laryngeal Squamous Cell Carcinoma, Stage IVA Oral Cavity Squamous Cell Carcinoma, Stage IVA Oropharyngeal Squamous Cell Carcinoma, Stage IVB Hypopharyngeal Squamous Cell Carcinoma, Stage IVB Laryngeal Squamous Cell Carcinoma, Stage IVB Oral Cavity Squamous Cell Carcinoma, Stage IVB Oropharyngeal Squamous Cell Carcinoma, Stage IVC Hypopharyngeal Squamous Cell Carcinoma, Stage IVC Laryngeal Squamous Cell Carcinoma, Stage IVC Oral Cavity Squamous Cell Carcinoma, Stage IVC Oropharyngeal Squamous Cell Carcinoma
What this study did
NCT00253630 · National Cancer Institute (NCI)
2005-09 – 2016-05 · Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma
What this study did
NCT01578343 · Samsung Medical Center
2012-06 – 2016-02 · Mantle Cell Lymphoma
What this study did
NCT01738646 · Duke University
2013-01 – 2016-02 · Recurrent Glioblastoma Multiforme, Malignant Glioma, Adult Brain Tumor
What this study did
NCT01748240 · Groupe Francophone des Myelodysplasies
2013-03 – 2015-07 · Myelodysplastic Syndrome
What this study did
NCT01550224 · Steven E. Coutre
2013-05-01 – 2014-11-17 · Acute Myeloid Leukemia With 11q23-abnormality in Relapse
What this study did
NCT01000155 · Dana-Farber Cancer Institute
2009-10 – 2014-10 · Sickle Cell Disease, Sickle Cell Anemia
What this study did
NCT01500538 · Peter MacCallum Cancer Centre, Australia
2012-10 – 2014-05 · Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma
What this study did
NCT01789255 · National Cancer Institute (NCI)
2013-06 – 2014-03 · Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Graft Versus Host Disease, Intraocular Lymphoma, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Ringed Sideroblasts, Refractory Chronic Lymphocytic Leukemia, Refractory Cytopenia With Multilineage Dysplasia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Central Nervous System Hodgkin Lymphoma, Secondary Central Nervous System Non-Hodgkin Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia
What this study did
NCT00656617 · M.D. Anderson Cancer Center
2008-04 – 2014-02 · Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)
What this study did
NCT01600742 · National Taiwan University Hospital
2012-08 – 2013-12 · Brain Metastasis
What this study did
NCT00918489 · Heidelberg University
2010-05 – 2013-09 · Soft Tissue Sarcoma
What this study did
NCT00121225 · National Cancer Institute (NCI)
2005-09 – 2013-06 · Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Iris Melanoma, Uveal Melanoma, Recurrent Intraocular Melanoma, Recurrent Melanoma, Stage IV Melanoma
What this study did
Phase 1/2 (61)
Cutaneous T-Cell Lymphoma
NCT01187446 · Stanford University
2010-12 – 2014-02 · Cutaneous Lymphoma, Cutaneous T-cell Lymphoma
What this study did
NCT00601718 · University of Washington
2007-12 – 2010-06 · Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Waldenström Macroglobulinemia
What this study did
Other / comorbidity
NCT03167437 · National Institute of Allergy and Infectious Diseases (NIAID)
2017-10-30 – 2035-06-30 · Crohn's Disease
What this study did
NCT05848687 · Tanja Andrea Gruber
2023-11-03 – 2033-12 · Lymphoblastic Leukemia
What this study did
NCT02553460 · St. Jude Children's Research Hospital
2016-01-29 – 2031-10 · Acute Lymphoblastic Leukemia
What this study did
NCT01297764 · Hackensack Meridian Health
2011-04 – 2027-06 · Multiple Myeloma
What this study did
NCT02638090 · H. Lee Moffitt Cancer Center and Research Institute
2016-03-22 – 2027-06 · Lung Cancer, Non-small Cell Lung Cancer
What this study did
NCT00972478 · National Cancer Institute (NCI)
2010-11-15 – 2027-03-06 · Ann Arbor Stage II Non-Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma
What this study did
NCT00392353 · National Cancer Institute (NCI)
2006-11-22 – 2026-12-31 · Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Myelodysplastic Syndrome With Ring Sideroblasts, Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia
What this study did
NCT03842696 · University of Michigan Rogel Cancer Center
2020-02-04 – 2026-04-01 · Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase, Chronic Myelogenous Leukemia, Accelerated Phase, Chronic Myelogenous Leukemia, Blastic Phase, Myelodysplastic Syndromes, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Non Hodgkin Lymphoma, Graft Vs Host Disease, Graft-versus-host-disease
What this study did
NCT02836548 · The Netherlands Cancer Institute
2016-06 – 2023-11 · Melanoma, Skin Neoplasms
What this study did
NCT02538510 · University of Washington
2015-10-08 – 2023-09-15 · Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx Carcinoma, Recurrent Salivary Gland Carcinoma, Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary, Stage III Major Salivary Gland Carcinoma, Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Stage III Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma, Stage IVA Major Salivary Gland Carcinoma, Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Stage IVB Major Salivary Gland Carcinoma, Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Stage IVC Major Salivary Gland Carcinoma, Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
What this study did
NCT01193842 · National Cancer Institute (NCI)
2010-10-06 – 2022-05-19 · AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma, Ann Arbor Stage I Grade 3 Follicular Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Grade 3 Follicular Lymphoma, HIV Infection, Plasmablastic Lymphoma, Primary Effusion Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Grade 3 Follicular Lymphoma
What this study did
NCT01189266 · National Cancer Institute (NCI)
2010-08-09 – 2021-09-30 · Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma, Gliosarcoma
What this study did
NCT01879085 · Melissa Burgess, MD
2013-09-24 – 2021-04-15 · Sarcoma
What this study did
NCT01294670 · Memorial Sloan Kettering Cancer Center
2011-02-09 – 2020-12-08 · Solid Tumors, Relapsed/Refractory Sarcomas
What this study did
NCT00555399 · M.D. Anderson Cancer Center
2007-11-28 – 2020-01-24 · Glioblastoma Multiforme, Anaplastic Glioma
What this study did
NCT00731731 · National Cancer Institute (NCI)
2009-07-10 – 2019-11-01 · Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
What this study did
NCT03198559 · University of Melbourne
2017-08-08 – 2019-04-09 · HIV Infections
What this study did
NCT02589145 · M.D. Anderson Cancer Center
2016-06-22 – 2019-04-08 · Lymphoma
What this study did
NCT01983969 · M.D. Anderson Cancer Center
2013-11-07 – 2017-11-22 · Advanced Cancers, Lymphoma
What this study did
NCT00857324 · Tiziana Marangon
2009-03 – 2017-05 · Multiple Myeloma
What this study did
NCT01422499 · National Center for Tumor Diseases, Heidelberg
2012-03 – 2017-03-24 · Children With Relapsed Solid Tumor, Lymphoma or Leukemia
What this study did
NCT00667615 · Memorial Sloan Kettering Cancer Center
2008-04 – 2017-02 · Hodgkin's Disease, Lymphoma
What this study did
NCT01266031 · National Cancer Institute (NCI)
2011-07-12 – 2017-01-31 · Malignant Glioma, Recurrent Glioblastoma
What this study did
NCT02124083 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
2014-04-25 – 2016-12-13 · Neimann-Pick Disease
What this study did
NCT01120834 · Weill Medical College of Cornell University
2010-09 – 2016-10-20 · Lymphoma
What this study did
NCT00918723 · Fred Hutchinson Cancer Center
2009-06 – 2016-10 · Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage I Small Lymphocytic Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Small Lymphocytic Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Small Lymphocytic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Small Lymphocytic Lymphoma
What this study did
NCT01502085 · Hackensack Meridian Health
2011-12 – 2016-05 · Multiple Myeloma
What this study did
NCT01045538 · Asan Medical Center
2010-02 – 2016-04 · Gastric Cancer, Histone Deacetylase Inhibitor
What this study did
NCT01319383 · University of North Carolina, Chapel Hill
2011-02 – 2016-03-31 · HIV-1 Infection
What this study did
NCT02475915 · SEARCH Research Foundation
2015-01 – 2016-03 · Acute HIV Infection
What this study did
NCT01394354 · University Hospital Freiburg
2011-08 – 2015-12 · Multiple Myeloma in Relapse
What this study did
NCT00910000 · Dana-Farber Cancer Institute
2009-06 – 2015-10 · Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
What this study did
NCT01483690 · Therapeutic Advances in Childhood Leukemia Consortium
2011-12 – 2015-07-31 · Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia
What this study did
NCT00416130 · National University Hospital, Singapore
2007-01 – 2015-01 · Breast Cancer
What this study did
NCT01110876 · M.D. Anderson Cancer Center
2011-06 – 2014-07 · Brain Cancer, Glioblastoma Multiforme
What this study did
NCT00574587 · Albert Einstein College of Medicine
2007-12 – 2014-05 · Breast Cancer
What this study did
NCT00324740 · National Cancer Institute (NCI)
2006-03 – 2014-05 · Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
What this study did
NCT01027676 · National Cancer Center, Korea
2010-06 – 2014-03 · Non-Small-Cell Lung Carcinoma
What this study did
NCT00324870 · National Cancer Institute (NCI)
2006-02 – 2013-11 · Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
What this study did
NCT00948688 · Massachusetts General Hospital
2009-08 – 2013-11 · Pancreatic Cancer, Adenocarcinoma of the Pancreas
What this study did
NCT00895934 · National Cancer Institute (NCI)
2009-05 – 2013-09 · Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Recurrent Adult Acute Myeloid Leukemia
What this study did
NCT00810602 · Pavan Reddy, MD
2009-01 – 2013-07 · Hematologic Malignancies, Graft vs Host Disease
What this study did
NCT00939991 · Katy Peters
2009-10 – 2013-04 · Brain Tumor, Glioblastoma
What this study did
NCT00787527 · M.D. Anderson Cancer Center
2008-11 – 2012-12 · Lymphoma
What this study did
NCT00976183 · Gynecologic Oncology Associates
2009-10 – 2012-10 · Ovarian Neoplasms
What this study did
NCT01118975 · University of Maryland, Baltimore
2010-03 – 2012-10 · Breast Cancer, Neoplasm Metastasis
What this study did
NCT00972842 · Arbeitsgemeinschaft medikamentoese Tumortherapie
2009-09 – 2012-07 · Peripheral T-Cell Non-Hodgkin's Lymphoma
What this study did
Phase 1 (113)
Cutaneous T-Cell Lymphoma
NCT01567709 · National Cancer Institute (NCI)
2012-04-16 – 2018-03-29 · Adult B Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma, Chronic Lymphocytic Leukemia, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Hepatosplenic T-Cell Lymphoma, Intraocular Lymphoma, Lymphomatous Involvement of Non-Cutaneous Extranodal Site, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Nodal Marginal Zone Lymphoma, Primary Cutaneous B-Cell Non-Hodgkin Lymphoma, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides and Sezary Syndrome, Recurrent Non-Hodgkin Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Small Intestinal Lymphoma, Splenic Marginal Zone Lymphoma, T-Cell Large Granular Lymphocyte Leukemia, Testicular Lymphoma, Waldenstrom Macroglobulinemia
What this study did
NCT00499811 · National Cancer Institute (NCI)
2007-06 – 2011-08 · Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
What this study did
NCT00771472 · Merck Sharp & Dohme LLC
2008-08 – 2011-07 · Lymphoma
What this study did
NCT01116154 · City of Hope Medical Center
2010-05 – 2010-08 · Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-Cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenstrom Macroglobulinemia
What this study did
NCT00127101 · Merck Sharp & Dohme LLC
2005-09 – 2008-10 · Lymphoma
What this study did
Other / comorbidity
NCT04308330 · New York Medical College
2017-03-17 – 2027-12-31 · Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor, Neuroblastoma, Hepatoblastoma, Germ Cell Tumor
What this study did
NCT03843528 · Johns Hopkins All Children's Hospital
2019-05-01 – 2027-10-30 · Acute Myeloid Leukemia, Myelodysplastic Syndromes, Mixed Phenotype Acute Leukemia, Juvenile Myelomonocytic Leukemia
What this study did
NCT03150329 · City of Hope Medical Center
2017-09-01 – 2027-06-02 · Grade 3b Follicular Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic HL, Recurrent Classic Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3a Follicular Lymphoma, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma, Refractory B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic HL, Refractory Classic Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Follicular Lymphoma, Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Refractory Transformed Non-Hodgkin Lymphoma
What this study did
NCT00268385 · National Cancer Institute (NCI)
2005-12-16 – 2027-04-24 · Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Neoplasm
What this study did
NCT01281176 · National Cancer Institute (NCI)
2011-02-09 – 2027-04-17 · Adult Solid Neoplasm
What this study did
NCT00336063 · National Cancer Institute (NCI)
2006-03-03 – 2027-03-31 · Adult Nasal Type Extranodal NK/T-Cell Lymphoma, Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma, Recurrent Nasopharyngeal Undifferentiated Carcinoma, Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7
What this study did
NCT07150026 · Unravel Biosciences, Inc.
2026-03-15 – 2027-03-15 · Pitt Hopkins Syndrome
What this study did
NCT07150013 · Unravel Biosciences, Inc.
2026-03-15 – 2027-03-15 · Rett Syndrome
What this study did
NCT07217379 · University of North Carolina, Chapel Hill
2025-10-02 – 2027-02 · HIV (Human Immunodeficiency Virus)
What this study did
NCT06693284 · University of Minnesota
2025-11-20 – 2027-01-01 · Primary Malignant Peripheral Nerve Sheath Tumors
What this study did
NCT05317403 · Medical College of Wisconsin
2023-03-31 – 2027-01 · Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
What this study did
NCT03742245 · The Methodist Hospital Research Institute
2019-06-11 – 2026-12-01 · Breast Cancer Metastatic, Breast Cancer
What this study did
NCT01087554 · M.D. Anderson Cancer Center
2010-03 – 2026-08-18 · Advanced Cancer
What this study did
NCT03259503 · M.D. Anderson Cancer Center
2019-09-13 – 2025-11-05 · Recurrent Diffuse Large B-Cell Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma
What this study did
NCT02420613 · M.D. Anderson Cancer Center
2015-10-05 – 2025-03-28 · Diffuse Intrinsic Pontine Glioma
What this study did
NCT05700630 · Masonic Cancer Center, University of Minnesota
2024-07-15 – 2024-08-21 · HIV-1-infection, ART, Cd4+ Lymphocyte Deficiency, Lymphoid Tissue; Infection, Interleukin
What this study did
NCT03056495 · German Center for Neurodegenerative Diseases (DZNE)
2017-09-28 – 2024-03-04 · Alzheimer Disease
What this study did
NCT03332667 · New Approaches to Neuroblastoma Therapy Consortium
2018-09-12 – 2024-02-23 · Neuroblastoma
What this study did
NCT03426891 · H. Lee Moffitt Cancer Center and Research Institute
2018-03-16 – 2023-06-28 · Glioblastoma, Brain Tumor, GBM
What this study did
NCT02619253 · Nabil Adra
2016-02-23 – 2023-03-28 · Renal Cell Carcinoma, Urinary Bladder Neoplasms
What this study did
NCT01023737 · The University of Texas Health Science Center at San Antonio
2009-11 – 2023-01-08 · Malignant Solid Tumour
What this study did
NCT01608139 · M.D. Anderson Cancer Center
2012-11 – 2022-11 · Advanced Cancers
What this study did
NCT03212989 · University of North Carolina, Chapel Hill
2017-06-27 – 2022-07-05 · HIV-1 Infection
What this study did
NCT02349867 · Virginia Commonwealth University
2015-01-29 – 2022-05-13 · Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Stage III Pancreatic Cancer, Recurrent Pancreatic Carcinoma
What this study did
NCT03263936 · Therapeutic Advances in Childhood Leukemia Consortium
2017-07-11 – 2022-02-10 · Acute Myelogenous Leukemia
What this study did
NCT00867178 · National Cancer Institute (NCI)
2009-02-25 – 2021-12-22 · Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified
What this study did
NCT02083250 · M.D. Anderson Cancer Center
2014-03-06 – 2021-11-12 · Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia
What this study did
NCT01038388 · Emory University
2010-01-15 – 2021-08-05 · Multiple Myeloma
What this study did
NCT01266057 · M.D. Anderson Cancer Center
2011-04-28 – 2021-02-11 · Advanced Cancers
What this study did
NCT03803605 · University of North Carolina, Chapel Hill
2019-02-12 – 2021-01-28 · HIV-1 Infection
What this study did
NCT03878524 · OHSU Knight Cancer Institute
2020-04-01 – 2020-12-10 · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Anatomic Stage IV Breast Cancer AJCC v8, Anemia, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Castration-Resistant Prostate Carcinoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid System Neoplasm, Locally Advanced Pancreatic Adenocarcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Pancreatic Adenocarcinoma, Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Primary Myelofibrosis, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Hematologic Malignancy, Recurrent Hodgkin Lymphoma, Recurrent Myelodysplastic Syndrome, Recurrent Myelodysplastic/Myeloproliferative Neoplasm, Recurrent Myeloproliferative Neoplasm, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Refractory Chronic Lymphocytic Leukemia, Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Refractory Chronic Myelomonocytic Leukemia, Refractory Hematologic Malignancy, Refractory Hodgkin Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Myelodysplastic Syndrome, Refractory Myelodysplastic/Myeloproliferative Neoplasm, Refractory Non-Hodgkin Lymphoma, Refractory Plasma Cell Myeloma, Refractory Primary Myelofibrosis, Refractory Small Lymphocytic Lymphoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8, Unresectable Pancreatic Adenocarcinoma
What this study did
NCT00729118 · Ohio State University Comprehensive Cancer Center
2008-09-26 – 2020-05-04 · Multiple Myeloma, Plasma Cell Neoplasm
What this study did
NCT03022565 · University of Miami
2020-01 – 2020-01-29 · Uveal Melanoma
What this study did
NCT02042989 · M.D. Anderson Cancer Center
2014-06-27 – 2020-01-22 · Advanced Cancers
What this study did
NCT01059552 · Fox Chase Cancer Center
2009-12-16 – 2019-10-21 · Locally Advanced Non-small Cell Lung Cancer
What this study did
NCT01084057 · City of Hope Medical Center
2010-06-02 – 2019-09-27 · Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
What this study did
NCT01075113 · Virginia Commonwealth University
2010-08-10 – 2019-07-18 · Liver Cancer
What this study did
NCT03263533 · Virginia Commonwealth University
2017-04 – 2019-02 · Schizophrenia
What this study did
NCT03050450 · Johns Hopkins All Children's Hospital
2016-08-10 – 2018-12-19 · Central Nervous System Tumors
What this study did
NCT02108002 · National Institute of Neurological Disorders and Stroke (NINDS)
2014-04-05 – 2018-09-12 · Von Hippel-Lindau Disease
What this study did
NCT02707900 · University of North Carolina, Chapel Hill
2016-03 – 2018-07-11 · HIV-1 Infection
What this study did
NCT02151721 · Kanazawa University
2014-06-01 – 2018-02-20 · Non-Small-Cell Lung Carcinoma
What this study did
NCT01249443 · AIDS Malignancy Consortium
2013-11 – 2017-12 · HIV Infection, Recurrent Anal Cancer, Recurrent Breast Cancer, Recurrent Esophageal Cancer, Recurrent Gastric Cancer, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Non-small Cell Lung Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Anal Cancer, Stage IV Breast Cancer, Stage IV Esophageal Cancer, Stage IV Gastric Cancer, Stage IV Non-small Cell Lung Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Unspecified Adult Solid Tumor, Protocol Specific
What this study did
NCT01064921 · Ohio State University Comprehensive Cancer Center
2010-01-19 – 2017-11-08 · Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx
What this study did
NCT02412475 · Michael Burke
2015-02-21 – 2017-06-21 · Leukemia, Acute Myeloid
What this study did
Early phase / not applicable (5)
Other / comorbidity
NCT01720602 · University of Washington
2012-11 – 2020-01 · Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
What this study did
NCT01153672 · University of Washington
2010-11 – 2016-08-11 · Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
What this study did
NCT01695057 · University of Southern California
2012-10 – 2015-10 · Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
What this study did
NCT00735826 · Dartmouth-Hitchcock Medical Center
2009-03 – 2012-07 · Aerodigestive Tract Cancer, Lung Cancer, Esophageal Cancer, Head and Neck Cancer
What this study did
NCT01342757 · National Cancer Institute (NCI)
2010-12 – 2012-05 · Adult Glioblastoma, Depression, Recurrent Adult Brain Tumor
What this study did
Used as active comparator (3)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (1)
Cutaneous T-Cell Lymphoma
NCT01728805 · Kyowa Kirin, Inc.
2012-11 – 2021-02-17 · Cutaneous T-Cell Lymphoma
What this study did
Phase 2 (2)
Cutaneous T-Cell Lymphoma
NCT02943642 · Virogen Biotechnology Inc.
2026-05 – 2026-05-13 · Mycosis Fungoides
What this study did
NCT03713320 · miRagen Therapeutics, Inc.
2019-04-02 – 2020-12-01 · Cutaneous T-Cell Lymphoma/Mycosis Fungoides
What this study did

Competitive landscape

6 other tracked programmes target this mechanism, none of them ahead of this one.

This drug's own stage for Cutaneous T-Cell Lymphoma: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Vorinostat: this drugApprovedSmall moleculeHDACnot yet gradedNo reviewed efficacy summary in this indication
Brentuximab VedotinApprovedAntibody–drug conjugateAnti-CD30 antibody-drug conjugatePartial signal
NCT01578499: Percentage of Participants Achieving an Objective Response That Lasts at Least 4 Months (ORR4) (Each Cycle until disease progression, death End of treatment (Median overall follow-up 38.8 months)): Brentuximab Vedotin 54.7 percentage of participants (95% CI 42.5 to 66.9) | Methotrexate or Bexarotene 12.5 percentage of participants (95% CI 4.4 to 20.6)
Givinostat
Approved(overall)
Small moleculeHDAC
Reliable signal(overall)
No reviewed efficacy summary in this indication
RomidepsinApprovedSmall moleculeHDACnot yet gradedNo reviewed efficacy summary in this indication
Panobinostat
US approval withdrawn(overall)
Small moleculeHDAC
Partial signal(overall)
No reviewed efficacy summary in this indication
Chidamide
Phase 3(overall)
Small moleculeHDAC
Reliable signal(overall)
No reviewed efficacy summary in this indication
Purinostat Mesylate
Phase 3(overall)
Small moleculeHDAC
not yet graded(overall)
No reviewed efficacy summary in this indication
LacutamabPhase 2Monoclonal antibodyKIR3DL2not yet gradedNo reviewed efficacy summary in this indication
REC-2282
Discontinued
Small moleculeHDAC
not yet graded(overall)
No reviewed efficacy summary in this indication

Upcoming events

(15 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Vorinostat to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (6)
December 2026 (6)
Phase 2Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8Recruiting
Est. primary completion 2026-12-30 · NCT06145633 · CT.gov ↗
What to watch
Phase 1Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor, Neuroblastoma, Hepatoblastoma, Germ Cell TumorRecruiting
Est. primary completion 2026-12-31 · NCT04308330 · CT.gov ↗
What to watch
Phase 1Pitt Hopkins SyndromeRecruiting
Est. primary completion 2026-12-31 · NCT07150026 · CT.gov ↗
What to watch
Phase 1Rett SyndromeRecruiting
Est. primary completion 2026-12-31 · NCT07150013 · CT.gov ↗
What to watch
Phase 1/2Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome …Active not recruiting
Est. primary completion 2026-12-31 · NCT00392353 · CT.gov ↗
What to watch
Phase 2Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7Active not recruiting
Est. primary completion 2026-12-31 · NCT01587352 · CT.gov ↗
What to watch
2027 (4)
January 2027 (2)
Phase 1Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia RefractoryRecruiting
Est. primary completion 2027-01 · NCT05317403 · CT.gov ↗
What to watch
Phase 1Primary Malignant Peripheral Nerve Sheath TumorsRecruiting
Est. primary completion 2027-01-01 · NCT06693284 · CT.gov ↗
What to watch
June 2027 (1)
Phase 1/2Multiple MyelomaActive not recruiting
Est. primary completion 2027-06 · NCT01297764 · CT.gov ↗
What to watch
July 2027 (1)
Phase 1Acute Myeloid Leukemia, Myelodysplastic Syndromes, Mixed Phenotype Acute Leukemia, Juvenile Myelomonocytic LeukemiaActive not recruiting
Est. primary completion 2027-07-30 · NCT03843528 · CT.gov ↗
What to watch
2028 (2)
September 2028 (1)
Phase 2GVHDRecruiting
Est. primary completion 2028-09 · NCT06995521 · CT.gov ↗
What to watch
December 2028 (1)
Phase 1/2Lymphoblastic LeukemiaRecruiting
Est. primary completion 2028-12 · NCT05848687 · CT.gov ↗
What to watch
2030 (2)
September 2030 (1)
Phase 2NeuroblastomaRecruiting
Est. primary completion 2030-09 · NCT02559778 · CT.gov ↗
What to watch
December 2030 (1)
Phase 2NeuroblastomaNot yet recruiting
Est. primary completion 2030-12-31 · NCT07261241 · CT.gov ↗
What to watch
2035 (1)
June 2035 (1)
Phase 1/2Crohn's DiseaseRecruiting
Est. primary completion 2035-06-30 · NCT03167437 · CT.gov ↗
What to watch

See the full readout calendar ↗